Results

Total Results: 721 records

Showing results for "drug".

381. Aspirin for the Prevention of Cardiovascular Disease: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Q4J7tsThw_6nwfB-p-f5Hp
     March 01, 2009 - Nonsteroidal anti- inflammatory drug therapy combined with aspirin approx- imately quadruples the risk

382. Archived: Evidence Summary: Alcohol Misuse: Screening and Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/alcohol-misuse-screening-and-counseling-2004
     April 06, 2004 - Cochrane Drug and Alcohol Group. Guidelines to assess study quality. 2003. … Drug and Alcohol Review . 1990;10:313-21. 60. … Drug and Alcohol Review . 1996;15:29-38. 105. … education/ or exp drug abuse prevention/ or prevention.mp. 8 6 or 7 9 4 and 8 … CDAG = Cochrane Drug and Alcohol Group. Return to Table of Contents

383. Z8Avschjezubsjtdsx424H (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/z8AVsCHJEZUBSJtdSx424H
     May 23, 2019 - Cochrane Drug and Alcohol Group. Guidelines to assess study quality. 2003. … Drug and Alcohol Review. 1990;10:313-21. 60. … Drug and Alco- hol Review. 1996;15:29-38. 105. … education/ or exp drug abuse prevention/ or prevention.mp. 8 6 or 7 9 4 and 8 10 5 or 9 11 (randomized … CDAG � Cochrane Drug and Alcohol Group.

384. Archived: Final Evidence Review: Genital Herpes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review55/genital-herpes-screening-2005
     March 15, 2005 - There was no significant difference in drug elimination half-life or in time to peak concentration between … was more highly concentrated in the amniotic fluid, but there was no evidence of preferential fetal drug … harms. 50 Both acyclovir and valacyclovir have been designated pregnancy category B by the Food and Drug … $40-$80 $80-$160 $130 Notes: ELISA, enzyme-linked immunosorbent assay; FDA, Food and Drug … Notes: CNS, central nervous system; FDA, Food and Drug Administration; HSV, herpes simplex virus.

385. Screening for Genital Herpes Simplex: A Brief Update (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZzZp7_aoJn73k9z25w_-qr
     March 01, 2005 - ELISA, enzyme-linked immunosorbent assay; FDA, Food and Drug Administration; HSV, herpes simplex virus … There was no significant difference in drug elimination half-life or in time to peak concentration between … was more highly concentrated in the amniotic fluid, but there was no evidence of preferential fetal drug … harms.50 Both acyclovir and valacyclovir have been designated pregnancy category B by the Food and Drug … Summary of Evidence CNS, central nervous system; FDA, Food and Drug Administration; HSV, herpes simplex

386. doi:10.1016/S0749-3797(03)00122-3 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/hWzpnYXDpQzUr8U_5xY6qS
     January 01, 2003 - bothersome to interfere with adherence to the medica- tion regimen—are common, but serious adverse drug … pressure: overview of 162 American Journal of Preventive Medicine, Volume 25, Number 2 randomised drug

387. Kbjjfcap9Xvhkp43U-7B9Q (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KbJjfcaP9XvhkP43u-7b9q
     July 01, 2014 - Food and Drug Administration versus placebo or no treatment or first- line antiviral therapies (entecavir … did not respond to prior antiviral therapy or those who had virologic relapse and did not evaluate drug … For all analyses, we stratified results by antiviral drug. … Screening based on behavioral risk factors, such as injection drug use and high-risk sexual behaviors … In particular, entecavir and tenofovir have potent antiviral activity, seem to have low rates of drug

388. Archived: Ovarian Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening-2012
     September 15, 2012 - Food and Drug Administration for clinical use in ovarian cancer screening (it was submitted to the U.S … Food and Drug Administration for review in August 2010); pilot studies of its test characteristics are

389. High-Priority Evidence Gaps For Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/rtc2016rev_2%20(3).pdf
     December 01, 2016 - Screening for Intimate Partner Violence, Illicit Drug Use, and Mental Health Conditions 2. … Screening for Illicit Drug Use in Primary Care In the Affordable Care Act, Congress also requested … Food and Drug Administration–approved pharmacotherapy for cessation to adults who use tobacco. … I Drug Use, Illicit: Primary Care Interventions for Children and Adolescents The USPSTF concludes that … I Drug Use, Illicit: Screening in Adolescents, Adults, and Pregnant Women The USPSTF concludes that

390. Final Research Plan: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cervical-cancer-screening
     October 29, 2015 - Food and Drug Administration include: the Hybrid Capture 2 High-Risk HPV DNA Test (Digene Corp., Gaithersburg

391. Screening for Hepatitis B Virus Infection - Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/_YbH4zWjUdppo-uWMUg4qC
     February 01, 2004 - HBV infection in the United States include diagnosis with a sexually transmitted disease, intravenous drug

392. Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/38JVCyPEw7CNrmZN6twpM6
     July 01, 2021 - because their sensitivity and specificity are high for detecting these infections.17 The US Food and Drug … US Food and Drug Administration. Published May 23, 2019.

393. Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/YSDv4kYjdr7xnL3yLz2aSx
     December 27, 2019 - attending an STI clinic, sexual and gender minorities, persons living with HIV, persons with injection drug

394. Evidence Summary: Sexually Transmitted Infections: Behavioral Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/sexually-transmitted-infections-behavioral-counseling
     August 18, 2020 - that focused solely on behavior change to prevent unintended pregnancy or change behaviors such as drug … School of Medicine); and 3 federal partners: the Centers for Disease Control and Prevention, US Food and Drug … A randomized controlled trial utilizing motivational interviewing to reduce HIV risk and drug use in … community-based health clinic 268 Women and men, aged ≥18 y, psychiatric outpatients with alcohol or drug … et al, 69 2018 Fair US; prenatal or OB/GYN 50 Pregnant women at risk for STI/HIV and alcohol/drug

395. Recommendation: Skin Cancer Prevention: Behavioral Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/skin-cancer-counseling
     March 20, 2018 - The US Food and Drug Administration (FDA) provides information to help guide patients and clinicians … Food and Drug Administration. Sunscreen: how to help protect your skin from the sun. … Food and Drug Administration. Indoor tanning: the risks of ultraviolet rays.

396. Final Research Plan: Sexually Transmitted Infections: Behavioral Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/sexually-transmitted-infections-behavioral-counseling
     August 02, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Sexually Transmitted Infections: Behavioral Counseling August 02, 2018 Recommendations made by the USPSTF are independent of the U.S. government. They sh…

397. Screening for Anxiety in Children and Adolescents: US Preventive Services Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/qWZxPBqpffTYVNvGYPkohz
     May 01, 2021 - depression and suicide risk in children and adolescents • Primary care–based interventions for illicit drug … a serotonin–norepinephrine reuptake in- hibitor, is the only medication approved by the US Food and Drug … Primary care–based interventions to prevent illicit drug use in children, adolescents, and young adults

398. Screening for Syphilis Infection During Pregnancy: USPSTF Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/YJtsbuhNtrLyn6NpJZtfXk
     April 24, 2023 - have a history of HIV, incarceration, or multiple sexual partners; engage in sex in combination with drug … US Food and Drug Administration. … Drug allergy: an updated practice parameter.

399. Archived: Final Evidence Summary: Obesity in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary39/obesity-in-children-and-adolescents-screening-2010
     January 15, 2010 - Only 1 medication (orlistat) has been approved by the US Food and Drug Administration for prescription … The US Food and Drug Administration (FDA) approved the lipase inhibitor orlistat for prescription use … US Food and Drug Administration. Xenical approval letter. … US Food and Drug Administration. Meridia approval history. … , abstract, name of substance word, subject heading word] ((antiobesity or anti obesity) adj (drug

400. Archived: Gonorrhea: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/gonorrhea-screening-2005
     May 15, 2005 - sexually transmitted infections, new or multiple sexual partners, inconsistent condom use, sex work, and drug … Harms of treatment include adverse drug-related effects.